Contact Us
Drug Search Results
More Filters [+]

Mebendazole

Alternative Names: mebendazole, vermox, mebendazol, emverm
Latest Update: 2024-07-04
Latest Update Note: Clinical Trial Update

Product Description

Mebendazole is used to treat infections caused by worms. It works by keeping the worm from absorbing sugar (glucose), so that the worm loses energy and dies.  (Sourced from: https://www.mayoclinic.org/drugs-supplements/mebendazole-oral-route/side-effects/drg-20064631?p=1)

Mechanisms of Action: Tubulin Inhibitor,Glucose Uptake Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Hookworm Infections

Known Adverse Events: Abdominal Pain | Pain Unspecified | Stevens-Johnson Syndrome | Agranulocytosis | Neutropenia | Drug Hypersensitivity | Pregnancy Outcomes | Pregnancy, Abdominal | Pregnancy, Prolonged | Anorexia | Diarrhea | Flatulence

Company: Johnson & Johnson
Company Location: NEW BRUNSWICK NJ 08933
Company CEO: Joaquin Duato
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mebendazole

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Astrocytoma|Glioblastoma|Gliosarcoma|Optic Nerve Glioma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CCMC1411

P2

Completed

Gliosarcoma|Optic Nerve Glioma|Glioblastoma|Astrocytoma

2024-04-01

Recent News Events

Date

Type

Title

04/09/2024

News Article

 Public advisory - Unauthorized health products seized from Vanette Keast Health Consulting in Red Deer, Alberta may pose serious health risks

01/17/2024

News Article

 Trading Heats Up For This Micro Cap

10/03/2023

News Article

 [2023-2031] 5G Wireless Base Station Market Latest Sales Figure Signals more Opportunities Ahead

10/03/2023

News Article

 Cat Hairball Remedies Market Size, Growth & Forecast Report [2030]

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions